Reduction in utilization of radiation for heterotopic ossification prophylaxis following acetabular surgery during the COVID-19 pandemic.

Publication date: May 22, 2026

Heterotopic ossification (HO) is common following acetabular surgery. Evidence comparing external beam radiation (XRT) and nonsteroidal anti-inflammatory drugs (NSAIDs) for HO prophylaxis remains conflicting. This study evaluated changes in XRT utilization during the COVID-19 pandemic and compared the efficacy of XRT versus NSAIDs. A retrospective review was conducted of 180 patients undergoing open acetabular fracture fixation at a level 1 trauma center from 2018 to 2021. High-risk patients received XRT or indomethacin if XRT was declined. Outcomes included prophylaxis method, severe (Brooker 3 or 4) HO, and HO resection. XRT utilization decreased significantly during the pandemic (74. 3% vs. 28. 0%, P 

Concepts Keywords
Covid Acetabulum
Nonsteroidal Adult
Nsaids Aged
Pandemic Anti-Inflammatory Agents, Non-Steroidal
Surgery Anti-Inflammatory Agents, Non-Steroidal
COVID-19
COVID-19
External beam radiation
Female
Fractures, Bone
Heterotopic ossification
Humans
Indomethacin
Indomethacin
Male
Middle Aged
Ossification, Heterotopic
Pandemic
Postoperative Complications
Prophylaxis
Retrospective Studies
SARS-CoV-2

Semantics

Type Source Name
disease MESH heterotopic ossification
disease MESH COVID-19 pandemic
drug DRUGBANK Tricyclazole
disease MESH trauma
drug DRUGBANK Indometacin
disease MESH included
disease MESH Fractures Bone
disease MESH Postoperative Complications

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *